BioCardia, Inc. (BCDA) vs Palatin Technologies, Inc. (PTN)

BioCardia, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. BioCardia, Inc. and Palatin Technologies, Inc. are of similar size ($17.5M and $16.2M). BioCardia, Inc. has negative trailing earnings, so its P/E is not meaningful; Palatin Technologies, Inc. trades at 2.4×. Palatin Technologies, Inc. grew revenue faster over the last twelve months: 86.5% against 0.71%. BioCardia, Inc. has the higher net margin (0.00% vs −47.2%) and the higher return on invested capital (0.00% vs −942.3%). Across the 16 metrics below, Palatin Technologies, Inc. leads on 11 and BioCardia, Inc. on 5.

Valuation

Metric BCDA PTN Biotechnology median
P/E n/m 2.43 7.88
P/S 29.67 2.99 11.47
P/B 4.70 3.73 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 23.31 2.23 10.73
Earnings yield (60.95%) 41.20% (28.84%)
Free cash flow yield (59.63%) (37.93%) (23.03%)

Profitability

Metric BCDA PTN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin 0.00% (49.26%) 0.00%
Net margin 0.00% (47.22%) 0.00%
Free cash flow margin 0.00% (113.25%) 0.00%
Return on equity (1,803.19%) (297.25%) (57.72%)
Return on assets (214.47%) (73.72%) (49.22%)
Return on invested capital 0.00% (942.30%) 0.00%

Growth

Metric BCDA PTN Biotechnology median
Revenue growth (TTM) 0.71% 86.46% 5.64%
EPS growth (last fiscal year) 57.59% 68.15% —
Revenue growth, 5-year CAGR 26.89% (40.52%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.09 5.04 4.73
Net debt to EBITDA 0.30 0.15 0.96

Dividend

Metric BCDA PTN Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCDA PTN Biotechnology median
Market cap 16.20m 17.49m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack